PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
104.56%
Net income growth above 1.5x ORCL's 56.15%. David Dodd would see a clear bottom-line advantage if it is backed by stable operations.
24.10%
Some D&A expansion while ORCL is negative at -5.17%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
-1125.93%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
-632.09%
Negative yoy SBC while ORCL is 0.00%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
-153.87%
Both reduce yoy usage, with ORCL at -33.75%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-55.95%
AR is negative yoy while ORCL is 0.00%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-163.83%
Both reduce yoy usage, with ORCL at -33.75%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
186.91%
Lower 'other non-cash' growth vs. ORCL's 17300.00%, indicating steadier reported figures. David Dodd would confirm no missed necessary write-downs or gains.
-66.64%
Negative yoy CFO while ORCL is 82.11%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
-161.50%
Both yoy lines negative, with ORCL at -9.76%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
No Data
No Data available this quarter, please select a different quarter.
-32.48%
Both yoy lines negative, with ORCL at -17.45%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
58.42%
We have some liquidation growth while ORCL is negative at -10.36%. John Neff notes a short-term liquidity advantage if competitor is holding or restricted.
No Data
No Data available this quarter, please select a different quarter.
600.00%
We have mild expansions while ORCL is negative at -1298.11%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
No Data
No Data available this quarter, please select a different quarter.
128.17%
Stock issuance far above ORCL's 73.85%. Michael Burry flags a significant dilution risk vs. competitor’s approach unless ROI is very high.
100.00%
Buyback growth of 100.00% while ORCL is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.